{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:12:31Z","timestamp":1789261951538,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aging is a major risk factor for many chronic diseases. This study aimed to examine the effects of antihypertensive, lipid-lowering, and antidiabetic drugs on biological aging. We included 672 participants and 2746 repeated measurements from the Swedish Adoption\/Twin Study of Aging. Self-reported medicine uses were categorized into antidiabetic, antihypertensive, and lipid-lowering drugs. A total of 12 biomarkers for biological aging (BA biomarkers) were included as outcomes. Conditional generalized estimating equations were applied conditioning on individuals to estimate the drug effect on BA biomarker level within the same person when using or not using the drug. Chronological age, body mass index, smoking status, number of multiple medication uses, blood pressure, blood glucose level, and apoB\/apoA ratio were adjusted for as covariates in the model. Overall, using antihypertensive drugs was associated with a decrease in one DNA-methylation age (PCGrimAge: beta = \u2212 0.39, 95%CI = \u2212 0.67 to \u2212 0.12). When looking into drug subcategories, calcium channel blockers (CCBs) were associated with a decrease in several DNA-methylation ages (PCHorvathAge beta = \u2212 1.28, 95%CI = \u2212 2.34 to \u2212 0.21; PCSkin&amp;bloodAge beta = \u2212 1.34, 95%CI = \u2212 2.61 to \u2212 0.07; PCPhenoAge beta = \u2212 1.74, 95%CI = \u2212 2.58 to \u2212 0.89; PCGrimAge beta = \u2212 0.57, 95%CI = \u2212 0.96 to \u2212 0.17) and in functional biological ages (functional age index beta = \u2212 2.18, 95%CI = \u2212 3.65 to \u2212 0.71; frailty index beta = \u2212 1.31, 95%CI = \u2212 2.43 to \u2212 0.18). However, the results within other drug subcategories were inconsistent. Calcium channel blockers may decrease biological aging captured by the BA biomarkers measured at epigenetic and functional level. Future studies are warranted to confirm these effects and understand the underlying biological mechanisms.<\/jats:p>","DOI":"10.1007\/s11357-023-00784-8","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T02:02:43Z","timestamp":1681092163000},"page":"2065-2078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging"],"prefix":"10.1007","volume":"45","author":[{"given":"Bowen","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvid","family":"Sj\u00f6lander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Johnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav","family":"Thambisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra A.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juulia","family":"Jylh\u00e4v\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2452-1500","authenticated-orcid":false,"given":"Sara","family":"H\u00e4gg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"issue":"4","key":"784_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","volume":"159","author":"BK Kennedy","year":"2014","unstructured":"Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159(4):709\u201313.","journal-title":"Cell."},{"issue":"4","key":"784_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.tem.2022.01.007","volume":"33","author":"A Moskalev","year":"2022","unstructured":"Moskalev A, Guvatova Z, Lopes IDA, Beckett CW, Kennedy BK, De Magalhaes JP, et al. Targeting aging mechanisms: pharmacological perspectives. Trends Endocrinol Metab. 2022;33(4):266\u201380.","journal-title":"Trends Endocrinol Metab."},{"issue":"9","key":"784_CR3","doi-asserted-by":"publisher","first-page":"616","DOI":"10.18632\/aging.100799","volume":"7","author":"A Moskalev","year":"2015","unstructured":"Moskalev A, Chernyagina E, de Magalh\u00e3es JP, Barardo D, Thoppil H, Shaposhnikov M, et al. Geroprotectors.org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease. Aging. (Albany NY). 2015;7(9):616\u201328.","journal-title":"Aging. (Albany NY)"},{"issue":"3","key":"784_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/acel.12585","volume":"16","author":"D Barardo","year":"2017","unstructured":"Barardo D, Thornton D, Thoppil H, Walsh M, Sharifi S, Ferreira S, et al. The DrugAge database of aging-related drugs. Aging Cell. 2017;16(3):594\u20137.","journal-title":"Aging Cell."},{"key":"784_CR5","doi-asserted-by":"publisher","first-page":"233372142110464","DOI":"10.1177\/23337214211046419","volume":"7","author":"T Lohman","year":"2021","unstructured":"Lohman T, Bains G, Berk L, Lohman E. Predictors of biological age: the implications for wellness and aging research. Gerontol Geriatr Med. 2021;7:23337214211046419.","journal-title":"Gerontol Geriatr Med."},{"key":"784_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ebiom.2017.03.046","volume":"21","author":"J Jylh\u00e4v\u00e4","year":"2017","unstructured":"Jylh\u00e4v\u00e4 J, Pedersen NL, H\u00e4gg S. Biological Age Predictors EBioMedicine. 2017;21:29\u201336.","journal-title":"Biological Age Predictors EBioMedicine."},{"issue":"12","key":"784_CR7","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1093\/gerona\/glz155","volume":"74","author":"D Finkel","year":"2019","unstructured":"Finkel D, Stern\u00e4ng O, Jylh\u00e4v\u00e4 J, Bai G, Pedersen NL. Functional aging index complements frailty in prediction of entry into care and mortality. J Gerontol: Series A. 2019;74(12):1980\u20136.","journal-title":"J Gerontol: Series A."},{"issue":"7","key":"784_CR8","doi-asserted-by":"publisher","first-page":"9419","DOI":"10.18632\/aging.202913","volume":"13","author":"KN Fitzgerald","year":"2021","unstructured":"Fitzgerald KN, Hodges R, Hanes D, Stack E, Cheishvili D, Szyf M, et al. Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial. Aging. 2021;13(7):9419\u201332.","journal-title":"Aging."},{"issue":"22","key":"784_CR9","first-page":"22445","volume":"12","author":"Y Hachmo","year":"2020","unstructured":"Hachmo Y, Hadanny A, Abu Hamed R, Daniel-Kotovsky M, Catalogna M, Fishlev G, et al. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. Aging (Albany NY). 2020;12(22):22445\u201356.","journal-title":"Aging (Albany NY)."},{"issue":"6","key":"784_CR10","doi-asserted-by":"publisher","first-page":"e13028","DOI":"10.1111\/acel.13028","volume":"18","author":"GM Fahy","year":"2019","unstructured":"Fahy GM, Brooke RT, Watson JP, Good Z, Vasanawala SS, Maecker H, et al. Reversal of epigenetic aging and immunosenescent trends in humans. Aging Cell. 2019;18(6):e13028.","journal-title":"Aging Cell."},{"issue":"10","key":"784_CR11","doi-asserted-by":"publisher","first-page":"e13439","DOI":"10.1111\/acel.13439","volume":"20","author":"G Fiorito","year":"2021","unstructured":"Fiorito G, Caini S, Palli D, Bendinelli B, Saieva C, Ermini I, et al. DNA methylation-based biomarkers of aging were slowed down in a two-year diet and physical activity intervention trial: the DAMA study. Aging Cell. 2021;20(10):e13439.","journal-title":"Aging Cell."},{"key":"784_CR12","first-page":"1","volume":"347","author":"CM Hales","year":"2019","unstructured":"Hales CM, Servais J, Martin CB, Kohen D. Prescription Drug Use Among Adults Aged 40-79 in the United States and Canada. NCHS Data Brief. 2019;347:1\u20138.","journal-title":"NCHS Data Brief."},{"issue":"5","key":"784_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jalz.2011.05.2414","volume":"8","author":"ML Johnson","year":"2012","unstructured":"Johnson ML, Parikh N, Kunik ME, Schulz PE, Patel JG, Chen H, et al. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimer's & Dementia. 2012;8(5):437\u201344.","journal-title":"Alzheimer's & Dementia."},{"issue":"9242","key":"784_CR14","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","volume":"356","author":"H Jick","year":"2000","unstructured":"Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. The Lancet. 2000;356(9242):1627\u201331.","journal-title":"The Lancet."},{"issue":"9","key":"784_CR15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1158\/1940-6207.CAPR-13-0424","volume":"7","author":"S Gandini","year":"2014","unstructured":"Gandini S, Puntoni M, Heckman-Stoddard BM, Dunn BK, Ford L, DeCensi A, et al. Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. Cancer Prev Res. 2014;7(9):867\u201385.","journal-title":"Cancer Prev Res."},{"issue":"6","key":"784_CR16","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s11357-012-9498-3","volume":"35","author":"SR Spindler","year":"2013","unstructured":"Spindler SR, Mote PL, Li R, Dhahbi JM, Yamakawa A, Flegal JM, et al. \u03b21-Adrenergic receptor blockade extends the life span of Drosophila and long-lived mice. Age (Dordr). 2013;35(6):2099\u2013109.","journal-title":"Age (Dordr)."},{"issue":"5","key":"784_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11357-016-9948-4","volume":"38","author":"SR Spindler","year":"2016","unstructured":"Spindler SR, Mote PL, Flegal JM. Combined statin and angiotensin-converting enzyme (ACE) inhibitor treatment increases the lifespan of long-lived F1 male mice. AGE. 2016;38(5):379\u201391.","journal-title":"AGE."},{"issue":"6","key":"784_CR18","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.18632\/aging.102951","volume":"12","author":"W Liu","year":"2020","unstructured":"Liu W, Lin H, Mao Z, Zhang L, Bao K, Jiang B, et al. Verapamil extends lifespan in Caenorhabditis elegans by inhibiting calcineurin activity and promoting autophagy. Aging (Albany NY). 2020;12(6):5300\u201317.","journal-title":"Aging (Albany NY)."},{"issue":"1","key":"784_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10522-020-09907-6","volume":"22","author":"A Ito","year":"2021","unstructured":"Ito A, Zhao Q, Tanaka Y, Yasui M, Katayama R, Sun S, et al. Metolazone upregulates mitochondrial chaperones and extends lifespan in Caenorhabditis elegans. Biogerontology. 2021;22(1):119\u201331.","journal-title":"Biogerontology."},{"issue":"24","key":"784_CR20","doi-asserted-by":"crossref","first-page":"E2501","DOI":"10.1073\/pnas.1321776111","volume":"111","author":"W De Haes","year":"2014","unstructured":"De Haes W, Frooninckx L, Van Assche R, Smolders A, Depuydt G, Billen J, et al. Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. Proc Natl Acad Sci U S A. 2014;111(24):E2501\u20139.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"784_CR21","doi-asserted-by":"publisher","first-page":"14604","DOI":"10.18632\/aging.203115","volume":"13","author":"M Kho","year":"2021","unstructured":"Kho M, Wang YZ, Chaar D, Zhao W, Ratliff SM, Mosley TH, et al. Accelerated DNA methylation age and medication use among African Americans. Aging. 2021;13(11):14604\u201329.","journal-title":"Aging."},{"issue":"11","key":"784_CR22","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.18632\/aging.101626","volume":"10","author":"X Gao","year":"2018","unstructured":"Gao X, Colicino E, Shen J, Just AC, Nwanaji-Enwerem JC, Wang C, et al. Accelerated DNA methylation age and the use of antihypertensive medication among older adults. Aging. 2018;10(11):3210\u201328.","journal-title":"Aging."},{"issue":"6","key":"784_CR23","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/aje\/kwy060","volume":"187","author":"DW Belsky","year":"2018","unstructured":"Belsky DW, Moffitt TE, Cohen AA, Corcoran DL, Levine ME, Prinz JA, et al. Eleven telomere, epigenetic clock, and biomarker-composite quantifications of biological aging: do they measure the same thing? Am J Epidemiol. 2018;187(6):1220\u201330.","journal-title":"Am J Epidemiol."},{"key":"784_CR24","doi-asserted-by":"crossref","unstructured":"Allison P. Fixed effects regression models. California: Thousand Oaks; 2009. Available from: https:\/\/methods.sagepub.com\/book\/fixed-effects-regression-models.\u00a0Accessed 15 June\u00a02022.","DOI":"10.4135\/9781412993869"},{"issue":"2\u20133","key":"784_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/13825580490511152","volume":"11","author":"D Finkel","year":"2004","unstructured":"Finkel D, Pedersen NL. Processing speed and longitudinal trajectories of change for cognitive abilities: the Swedish Adoption\/Twin Study of Aging. Aging, Neuropsychol, and Cogn. 2004;11(2\u20133):325\u201345.","journal-title":"Aging, Neuropsychol, and Cogn"},{"issue":"7","key":"784_CR26","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.18632\/aging.100995","volume":"8","author":"K Berglund","year":"2016","unstructured":"Berglund K, Reynolds CA, Ploner A, Gerritsen L, Hovatta I, Pedersen NL, et al. Longitudinal decline of leukocyte telomere length in old age and the association with sex and genetic risk. Aging (Albany NY). 2016;8(7):1398\u2013415.","journal-title":"Aging (Albany NY)."},{"issue":"2","key":"784_CR27","doi-asserted-by":"publisher","first-page":"100014","DOI":"10.1016\/j.patter.2020.100014","volume":"1","author":"K Sugden","year":"2020","unstructured":"Sugden K, Hannon EJ, Arseneault L, Belsky DW, Corcoran DL, Fisher HL, et al. Patterns of reliability: assessing the reproducibility and integrity of DNA methylation measurement. Patterns. 2020;1(2):100014.","journal-title":"Patterns."},{"issue":"7","key":"784_CR28","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s43587-022-00248-2","volume":"2","author":"AT Higgins-Chen","year":"2022","unstructured":"Higgins-Chen AT, Thrush KL, Wang Y, Minteer CJ, Kuo P-L, Wang M, et al. A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking. Nat Aging. 2022;2(7):644\u201361.","journal-title":"Nat Aging."},{"key":"784_CR29","doi-asserted-by":"publisher","first-page":"e73420","DOI":"10.7554\/eLife.73420","volume":"11","author":"DW Belsky","year":"2022","unstructured":"Belsky DW, Caspi A, Corcoran DL, Sugden K, Poulton R, Arseneault L, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022;11:e73420.","journal-title":"eLife."},{"key":"784_CR30","doi-asserted-by":"publisher","first-page":"e51507","DOI":"10.7554\/eLife.51507","volume":"9","author":"X Li","year":"2020","unstructured":"Li X, Ploner A, Wang Y, Magnusson PK, Reynolds C, Finkel D, et al. Longitudinal trajectories, correlations and mortality associations of nine biological ages across 20-years follow-up. Elife. 2020;9:e51507.","journal-title":"Elife."},{"issue":"1","key":"784_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1037\/0012-1649.41.1.3","volume":"41","author":"CA Reynolds","year":"2005","unstructured":"Reynolds CA, Finkel D, McArdle JJ, Gatz M, Berg S, Pedersen NL. Quantitative genetic analysis of latent growth curve models of cognitive abilities in adulthood. Dev Psychol. 2005;41(1):3\u201316.","journal-title":"Dev Psychol."},{"issue":"10","key":"784_CR32","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1093\/gerona\/glaa106","volume":"75","author":"E Raymond","year":"2020","unstructured":"Raymond E, Reynolds CA, Dahl Aslan AK, Finkel D, Ericsson M, H\u00e4gg S, et al. Drivers of frailty from adulthood into old age: results from a 27-year longitudinal population-based study in Sweden. J Gerontol: Series A. 2020;75(10):1943\u201350.","journal-title":"J Gerontol: Series A."},{"issue":"7","key":"784_CR33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726\u201335.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"784_CR34","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fpsyg.2017.00456","volume":"8","author":"JZ Bakdash","year":"2017","unstructured":"Bakdash JZ, Marusich LR. Repeated Measures Correlation. Front Psychol. 2017;8:456.","journal-title":"Front Psychol."},{"key":"784_CR35","doi-asserted-by":"publisher","first-page":"303728","DOI":"10.1155\/2014\/303728","volume":"2014","author":"M Wang","year":"2014","unstructured":"Wang M. Generalized Estimating Equations in Longitudinal Data Analysis: A Review and Recent Developments. Adv Stat. 2014;2014:303728.","journal-title":"Adv Stat."},{"issue":"1","key":"784_CR36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/em-2014-0021","volume":"4","author":"J Zetterqvist","year":"2015","unstructured":"Zetterqvist J, Sj\u00f6lander A. Doubly robust estimation with the R package drgee. Epidemiol Methods. 2015;4(1):69\u201386.","journal-title":"Epidemiol Methods."},{"issue":"6","key":"784_CR37","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/jgs.14155","volume":"64","author":"SY Chuang","year":"2016","unstructured":"Chuang SY, Pan WH, Chang HY, Wu C, Chen CY, Hsu CC. Protective effect of calcium channel blockers against frailty in older adults with hypertension. J Am Geriatr Soc. 2016;64(6):1356\u20138.","journal-title":"J Am Geriatr Soc."},{"key":"784_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.maturitas.2022.03.001","volume":"162","author":"L Rouch","year":"2022","unstructured":"Rouch L, Rolland Y, Hanon O, Vidal J-S, Cestac P, Sallerin B, et al. Blood pressure, antihypertensive drugs, and incident frailty: the Multidomain Alzheimer Preventive Trial (MAPT). Maturitas. 2022;162:8\u201314.","journal-title":"Maturitas."},{"issue":"7","key":"784_CR39","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jamda.2020.12.019","volume":"22","author":"M den Brok","year":"2021","unstructured":"den Brok M, van Dalen JW, Abdulrahman H, Larson EB, van Middelaar T, van Gool WA, et al. Antihypertensive medication classes and the risk of dementia: a systematic review and network meta-analysis. J Am Med Dir Assoc. 2021;22(7):1386\u201395.e15.","journal-title":"J Am Med Dir Assoc."},{"issue":"6","key":"784_CR40","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.21037\/apm-21-1272","volume":"10","author":"A Feng","year":"2021","unstructured":"Feng A, Wang W, Du C, He M. A systematic review and meta-analysis of early diagnosis and treatment of hypertensive stroke under calcium channel blockers. Ann Palliat Med. 2021;10(6):6715\u201325.","journal-title":"Ann Palliat Med."},{"key":"784_CR41","doi-asserted-by":"publisher","first-page":"117412","DOI":"10.1016\/j.jns.2021.117412","volume":"424","author":"YF Tseng","year":"2021","unstructured":"Tseng YF, Lin HC, Chao JC, Hsu CY, Lin HL. Calcium channel blockers are associated with reduced risk of Parkinson's disease in patients with hypertension: a population-based retrospective cohort study. J Neurol Sci. 2021;424:117412.","journal-title":"J Neurol Sci"},{"issue":"7","key":"784_CR42","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/aje\/kwr362","volume":"175","author":"B Pasternak","year":"2012","unstructured":"Pasternak B, Svanstr\u00f6m H, Nielsen NM, Fugger L, Melbye M, Hviid A. Use of calcium channel blockers and Parkinson's disease. Am J Epidemiol. 2012;175(7):627\u201335.","journal-title":"Am J Epidemiol."},{"issue":"5","key":"784_CR43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ana.21937","volume":"67","author":"B Ritz","year":"2010","unstructured":"Ritz B, Rhodes SL, Qian L, Schernhammer E, Olsen JH, Friis S. L-type calcium channel blockers and Parkinson disease in Denmark. Ann Neurol. 2010;67(5):600\u20136.","journal-title":"Ann Neurol."},{"issue":"7148","key":"784_CR44","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nature05865","volume":"447","author":"CS Chan","year":"2007","unstructured":"Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, et al. \u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson\u2019s disease. Nature. 2007;447(7148):1081\u20136.","journal-title":"Nature."},{"key":"784_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ceca.2017.04.001","volume":"70","author":"N Martin","year":"2018","unstructured":"Martin N, Bernard D. Calcium signaling and cellular senescence. Cell Calcium. 2018;70:16\u201323.","journal-title":"Cell Calcium."},{"key":"784_CR46","doi-asserted-by":"publisher","first-page":"111314","DOI":"10.1016\/j.mad.2020.111314","volume":"190","author":"SG Kim","year":"2020","unstructured":"Kim SG, Sung JY, Kim J-R, Choi HC. Nifedipine-induced AMPK activation alleviates senescence by increasing autophagy and suppressing of Ca2+ levels in vascular smooth muscle cells. Mech Ageing Dev. 2020;190:111314.","journal-title":"Mech Ageing Dev."},{"issue":"2","key":"784_CR47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14336\/AD.2014.0305","volume":"6","author":"F Bonomini","year":"2015","unstructured":"Bonomini F, Rodella LF, Rezzani R. Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis. 2015;6(2):109\u201320.","journal-title":"Aging Dis."}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-023-00784-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-023-00784-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-023-00784-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T11:43:03Z","timestamp":1702208583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-023-00784-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1007\/s11357-023-00784-8","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,10]]},"assertion":[{"value":"18 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}